Recombinant human thyroid stimulating hormone(Smartnuclide)

重组人促甲状腺素（苏州智核）

Report date: 2024/05/30 17:00:57

Base Information

Drug NameRecombinant human thyroid stimulating hormone(Smartnuclide)
Drug Alias Name重组人促甲状腺激素（苏州智核）智舒嘉SNA-001SNA001KN040 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionThyroid stimulating hormone receptor agonists
TargetsThyroid stimulating hormone receptor
Therapy Area/IndicationsThyroid Neoplasms
Global Approved IndicationsThyroid Neoplasms
Approved Indications in ChinaThyroid Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2024/04/02
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSmartnuclide Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesSmartnuclide Biopharma
Inactive CompaniesN/A
Active IndicationsThyroid Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A